G. Buccheri (Cuneo, Italy), J-P. Sculier (Brussels, Belgium)
Comparative epidemiology of lung cancer (prevalence, histology, stage at diagnosis and resectability rate) in North Teesside (UK) and in the Province of Varese (Italy)
A. Imperatori, D. N. Leitch, G. Dionigi, F. Rovera, G. Lepore, P. Alabardi, M. Bandera, V. Vavassori, P. Sutton, R. N. Harrison, L. Dominioni (Varese, Gallarate, Italy; Stockton on Tees, Hartlepool, United Kingdom)
|  |
Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer
G. Buccheri, D. Ferrigno (Cuneo, Italy)
| |
Quality of life as an independent prognostic parameter in lung cancer
N. Konietzko, S. Sohrab, U. Roggenbruck, K. H. Jöckel (Essen, Germany)
| |
C-kit (CD 117): a new prognostic factor in small cell lung cancer (SCLC)
P. Micke, M. Basrai, F. Bittinger, K. M. Beeh, B. Fischer, J. G. Hengstler, R. Buhl (Mainz, Germany)
| |
The role of EGFR expression in the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
A. P. Meert, B. Martin, P. Delmotte, T. Berghmans, J. J. Lafitte, F. Lemaitre, C. Mascaux, M. Paesmans, E. Steels, J. M. Verdebout, J. P. Sculier (Brussels, Belgium)
| |
The expression of Ki-67, a marker of proliferative activity, in resected nonsmall cell lung cancer
B. Martin, C. Mascaux, J. M. Verdebout, M. Paesmans, G. Rouas, A. Verhest, T. Bosschaerts, V. Ninane, J. P. Sculier (Brussels, Belgium)
| |
Clinical strategy in patients with multiple synchronous suspect lung lesions. A reflection on the current TNM classification based on 54 cases with complete follow-up
J. Vansteenkiste, B. De Belie, K. Nackaerts, P. De Leyn, D. Van Raemdonck, G. Deneffe, T. Lerut, M. Demedts, The Leuven Lung Cancer Group (Leuven, Belgium)
| |
Economic evaluation of the clinical management of lung cancer in France
A. Vergnenègre, L. Molinier, C. Combescure, M. P. Schuller-Lebeau, C. Chouaïd, J. P. Daurès (Limoges, Toulouse, Montpellier, Paris, France)
| |